10x Genomics, Inc.
NASDAQ:TXG
15.08 (USD) • At close January 17, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | 10x Genomics, Inc. |
Symbool | TXG |
Munteenheid | USD |
Prijs | 15.08 |
Beurswaarde | 1,825,501,151 |
Dividendpercentage | 0% |
52-weken bereik | 12.95 - 51.22 |
Industrie | Health Information Services |
Sector | Healthcare |
CEO | Dr. Serge Saxonov Ph.D. |
Website | https://www.10xgenomics.com |
An error occurred while fetching data.
Over 10x Genomics, Inc.
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)